NCT00370162已完成3 期
Safety Dermatological Evaluation: Acceptability With Gynecological Follow up - Dermacyd Delicata New Fragrance
适应症
相关药物
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- Sanofi
- 入组人数
- 30
- 试验地点
- 1
- 主要终点
- Adverse Events and its association with the drug in study
研究概览
简要总结
The purpose of this study is to demonstrate the safety of the gynaecological formulation in normal and usual usage condition.
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 60 Years（Adult）
- 性别
- Female
- 接受健康志愿者
- 是
入选标准
- •Integral skin in the tested region
排除标准
- •Pregnancy or breastfeeding women
- •Use of antiinflammatory or immunosuppression drugs
- •Topical medication use at the tested region
- •Active cutaneous gynaecological disease
- •Personal history of allergic disease at the area to be treated
- •Allergic or atopic history
结局指标
主要结局
Adverse Events and its association with the drug in study
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
已完成
3 期
Acceptability Dermacyd Wipes - Lactoserum - HygieneHygieneNCT00397527Sanofi30
已完成
4 期
Acceptability Lactoserum (Dermacyd Delicata - New Fragrance)HygieneNCT00497783Sanofi30
已完成
4 期
Acceptability of Lactacyd FeminaHygieneNCT00712868Sanofi559
已完成
4 期
Dermacyd Infantile - Acceptability.HygieneNCT00881270Sanofi31
已完成
3 期
Safety Dermatological Evaluation: Acceptability With Gynecological Follow up - Dermacyd Tina Gel Sweet FlowerHygieneNCT00663273Sanofi30